Circulating soluble LR11, a differentiation regulator for vascular cells, is increased during pregnancy and exaggerated in patients with pre-eclampsia
- 9 July 2019
- journal article
- research article
- Published by Elsevier BV in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 497, 172-177
- https://doi.org/10.1016/j.cca.2019.07.001
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (16H05231, 18 K07428)
- Naito Foundation
- Smoking Research Foundation
- Takeda Science Foundation
- Kurozumi Medical Foundation
- Uehara Memorial Foundation
This publication has 32 references indexed in Scilit:
- Pre‐eclampsia: fitting together the placental, immune and cardiovascular piecesThe Journal of Pathology, 2010
- Enhanced circulating soluble LR11 in patients with coronary organic stenosisAtherosclerosis, 2010
- Development of an Immunoassay for the Quantification of Soluble LR11, a Circulating Marker of AtherosclerosisClinical Chemistry, 2009
- The Global Impact of Pre-eclampsia and EclampsiaSeminars in Perinatology, 2009
- Ang II–stimulated migration of vascular smooth muscle cells is dependent on LR11 in miceJCI Insight, 2008
- Placental Origins of PreeclampsiaHypertension, 2008
- Triglyceride-Rich Lipoproteins Prime Aortic Endothelium for an Enhanced Inflammatory Response to Tumor Necrosis Factor-αCirculation Research, 2007
- Neutrophils Infiltrate Resistance-Sized Vessels of Subcutaneous Fat in Women With PreeclampsiaHypertension, 2004
- The Classification and Diagnosis of the Hypertensive Disorders of Pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP)Hypertension in Pregnancy, 2001
- Elements of Neural Adhesion Molecules and a Yeast Vacuolar Protein Sorting Receptor Are Present in a Novel Mammalian Low Density Lipoprotein Receptor Family MemberOnline Journal of Public Health Informatics, 1996